The FLCCC Physicians
How the FLCCC Alliance came together and developed effective treatment protocols for COVID-19 (March 10, 2021)
This is the story about how the FLCCC Alliance was formed—and how, at the start of the pandemic, the team quickly began to develop protocols to successfully treat patients. Their first protocol was the MATH+ Hospital Treatment Protocol that was used to save critically ill patients and to prevent them from having to rely on ventilators to breathe.
Subsequently, as COVID-19 cases surged, they urgently researched ways to offload the hospitals and reduce case counts and deaths. The team developed the I-MASK+ Prevention & Early Outpatient Treatment Protocol—centered around the drug ivermectin—which is effective for every phase of COVID-19 disease… from prevention through late phase illness.
The Front Line Covid-19 Critical Care Alliance was created by highly published critical care specialists from major academic medical centers with collectively over 1,000 medical publications. Based on the rapidly emerging research into COVID-19, the early clinical experience in China reflected by the Shanghai expert commission, and their decades-long clinical and research experiences in severe infectious diseases around the country, the 5 experts developed the MATH+ Hospital Treatment Protocol for Covid-19. It is intended for use early in the hospitalization of patients presenting with states of respiratory distress requiring supplemental oxygen. In October 2020, after reviewing numerous new studies from around the world on the antiparasitic drug ivermectin’s use in prophyaxis and all stages of treatment for COVID-19, the team created the I-MASK+ protocol for prevention and early outpatient treatment. These 5 physicians have since been joined by an increasing number of hospitalist and ICU physicians who recognize the sound physiologic rationale, the emerging published research in support of the components, and the data demonstrating good clinical outcomes in hospitals and communities that have adopted the treatment regimen.
Founding members / MATH+ and I-MASK+ developers
Paul E. Marik, M.D., FCCM, FCCP
- Endowed Professor of Medicine
- Chief, Div. of Pulmonary & Critical Care Medicine
- Eastern Virginia Medical School Norfolk, Virginia
- Curriculum Vitae – Dr. Paul E. Marik
Pierre Kory, M.D., M.P.A.
- Pulmonary and Critical Care Specialist
- President, Frontline COVID-19 Critical Care Alliance (FLCCC Alliance)
- Curriculum Vitae – Dr. Pierre Kory
G. Umberto Meduri, M.D.
- Professor of Medicine
University of Tennessee Health Science Center - Pulmonary, Critical Care & Sleep Medicine and Research Services
Memphis V.A. Medical Center - Curriculum Vitae – Dr. G. Umberto Meduri
Joseph Varon, M.D., FCCP, FCCM
- Professor of Acute & Continuing Care
- Chief of Staff & Chief of Critical Care
- United Memorial Medical Center, Houston, Texas
- Curriculum Vitae – Dr. Joseph Varon
Jose Iglesias, D.O.
- Assoc. Prof., Hackensack Meridian School of Medicine at Seton Hall
- Dept. of Nephrology & Critical Care / Community Medical Center
- Dept. of Nephrology, Jersey Shore University Medical Center
- Neptune, New Jersey
- Curriculum Vitae – Dr. Jose Iglesias
Founding members
Keith Berkowitz, M.D., M.B.A.
- Medical Director, Center for Balanced Health
- Voluntary Attending Physician, Lenox Hill Hosp. New York, New York
- Curriculum Vitae – Dr. Keith Berkowitz
Fred Wagshul, M.D.
- Pulmonologist & Med. Dir., Lung Center of America
- Clinical Instructor, Wright State University School of Medicine,
- Dayton, Ohio
- Curriculum Vitae – Dr. Fred Wagshul
Clinical advisors
Eivind H. Vinjevoll, M.D.
- Senior Consultant Anesthesiologist
- Intensive Care, Emergency Medicine, Anesthesia
- Volda, Norway
Scott Mitchell, MBChB
- Associate Specialist
- Emergency Department
- Princess Elizabeth Hospital
- States of Guernsey
Eric Osgood, M.D.
___
https://covid19criticalcare.com/about/the-flccc-physicians/